Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents

Investigational Site Number 788003, Tunis

Investigational Site Number 788002, Sousse

Investigational Site Number 504002, Rabat

Investigational Site Number 764001, Bangkok

Investigational Site Number 360001, Jakarta

Investigational Site Number 012001, Algiers

Investigational Site Number 504001, Casablanca

Investigational Site Number 380001, Milan

Investigational Site Number 792002, Istanbul

Investigational Site Number 792003, Abacıoğlu

Investigational Site Number 764002, Chiang Mai

Investigational Site Number 484001, Villahermosa

Investigational Site Number 250001, Villejuif

Investigational Site Number 156005, Fuzhou

Investigational Site Number 356003, Ahmedabad

Investigational Site Number 356001, Vellore

Investigational Site Number 356002, Thiruvananthapuram

Investigational Site Number 356004, Kolkata

Investigational Site Number 076002, Rio de Janeiro

Investigational Site Number 076001, São Paulo

Investigational Site Number 504003, Rabat

Investigational Site Number 608002, Quezon City

Investigational Site Number 410001, Seoul

Investigational Site Number 410003, Seoul

Investigational Site Number 410002, Seoul

Investigational Site Number 792001, Ankara